Australian Healthtech Medcast Raises US$3.79Mn to Expand MedLuma Clinical AI Platform
Sep 25, 2026 | By Nguyen Minh

Australian medical education and healthtech company Medcast has raised A$5.4 (US$3.79) million in a new investment round led by Best Practice Software. The funding will support the development and expansion of its AI powered clinical knowledge platform MedLuma.
The investment will help Medcast expand its technology and clinical teams, develop MedLuma and integrate the platform with clinical software used by healthcare professionals.
MedLuma’s Clinical AI Platform
MedLuma is an AI-enabled clinical knowledge platform designed for Australian healthcare professionals. It helps clinicians find answers to medical questions using Australian clinical guidelines and other verified medical sources.
The platform provides evidence-based answers with citations that allow clinicians to check the original sources. MedLuma also combines technical AI checks with human review and keeps Australian health data onshore.

How Medcast Plans to Use the A$5.4M Funding
Medcast will use the investment to expand its technology and clinical teams and continue developing MedLuma.
The company also plans to deepen MedLuma’s integration with clinical software, including Best Practice Software’s practice management systems. This will bring clinical knowledge closer to the tools healthcare professionals already use.
Best Practice Software Leads Medcast Investment
Best Practice Software led the A$5.4 million investment as part of its existing collaboration with Medcast.
Best Practice Software CEO Craig Hodges said the investment reflects confidence in the Medcast team and MedLuma platform. He also highlighted the opportunity to bring the technology into clinicians’ existing workflows.
Medcast CEO and co-founder Dr Stephen Barnett said the investment will help the company scale MedLuma while maintaining its focus on clinical quality, transparency and trust.
Medcast co-founder and Chief Product Officer Justin Lewis said the quality, sourcing and governance of medical information will be important for clinical AI adoption.
Medcast Funding & Growth
Founded in 2013, Medcast has provided clinical education and professional development to more than 100,000 registered healthcare professionals.
MedLuma launched in 2026 with an initial focus on Australian general practice. The platform is designed to help clinicians access relevant medical information faster while supporting professional development through CPD features.
About Medcast

Medcast is an Australian healthcare education and clinical knowledge company founded by Dr Stephen Barnett. The company provides evidence-based education, professional development and clinical resources for healthcare professionals.
Its MedLuma platform extends this work into AI-enabled clinical knowledge, giving healthcare professionals access to Australian guidelines and verified medical sources at the point of care.
Leadership Statements
Dr. Stephen Barnett, Founder & CEO of Medcast
“Medcast is proud to deepen our partnership with Best Practice. Together, we can expand access to trusted clinical guidance and education for clinicians across Australia. This collaboration allows us to combine our strengths and deliver tools that genuinely support safer care.”
“AI has enormous potential to improve healthcare by bringing the right information into the right context. But in clinical care, speed and convenience are not enough. Clinicians need information they can trust, grounded in evidence and Australian practice. Solving this ‘last mile’ of medical-grade AI is the hard problem we are tackling.”
Justin Lewis, Co-founder & Chief Product Officer of Medcast
“AI-powered search is becoming increasingly easy to build. Medical-grade AI that clinicians can interrogate and trust is much harder.”
“The opportunity for MedLuma is to create a trusted intelligence layer for Australian healthcare, bringing the right clinical knowledge into the flow of care.”
“It combines Australian-relevant evidence with transparent sourcing and responsible use of the intellectual property that underpins it.”
Read Also - groundcover Acquires Wand to Build Autonomous Infrastructure

















